ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Business/EarningsArticle

Kimberly-Clark flags near‑term earnings pressure as growth plan unfolds

The consumer‑goods maker sees Q3 revenue dip and EPS fall in the low‑teens, while outlining longer‑term targets and the impact of its Arbex joint venture and Kenvue acquisition.

PA
Priya Anand · Equities & Earnings Desk · 16 Sept 2026 · 06:30 · 2 min read
Share
Kimberly-Clark flags near‑term earnings pressure as growth plan unfolds

Kimberly-Clark (KMB) presented its outlook at Barclays' 19th Annual Global Consumer Conference on Sept. 9, 2026. Management highlighted a slowdown in organic sales growth, projecting a low‑single‑digit revenue contraction for the third quarter and earnings per share (EPS) down in the low‑teens versus a year earlier.

The company cited several near‑term headwinds. In China, a 250‑basis‑point impact is expected for Q3 and 100 basis points for the full year, trimming full‑year EPS by roughly $0.18. A delayed innovation launch in North America and disruptions in the professional‑business distribution network each shave about one percentage point from growth. Freight and logistics costs tied to a fire at the Los Angeles Distribution Center add an estimated $35‑$40 million in the second half, while retaliatory Canadian tariffs impose a $10 million drag. Incremental gross‑input cost inflation is built into the outlook at $150 million.

Kimberly-Clark’s market capitalization stands at $34.2 billion, with shares trading near $103 and a price‑to‑earnings multiple of 20.5. The dividend yield hovers close to 5%, marking 53 consecutive years of dividend increases. Organic sales growth slipped from 3.9% in 2024 to 1.7% in 2025, with category growth over the trailing 12 months ranging between 2% and 2.5%.

Geographically, the premium‑mix share in North America rose from about 70% to over 80%, while China’s premium mix climbed from 6% in 2019 to more than 50%. The Kleenex brand delivered roughly 7% compounded growth over the past three years.

Strategic initiatives were also discussed. The Arbex joint venture with Suzano, which combines 51% of Kimberly‑Clark’s international family‑ and professional‑care business, reduces the company’s exposure to fiber‑based inputs from 13‑15% of net sales to 6‑8%. Arbex itself will source 15% of its sales from fiber inputs.

The pending Kenvue acquisition, slated to close in Q4 2025, is expected to generate $500 million of incremental operating profit from revenue synergies, of which $300 million is earmarked for reinvestment. The combined entity will limit divestitures to no more than 1% of combined revenue and profit, and leadership will be split evenly between Kimberly‑Clark and Kenvue executives.

Long‑term guidance targets mid‑single‑digit EPS dilution versus the 2026 baseline for 2027, and mid‑ to high‑single‑digit EPS growth on a constant‑currency basis from 2028 onward.

Chairman and CEO Mike Hsu emphasized that the company is in its “10th quarter of volume and mix growth,” noting expanded margins and reduced earnings volatility. He warned against over‑promotion of categories, describing it as “pantry loading” that adds little value for consumers or retailers. Hsu also highlighted the alternative natural‑fiber program as a benefit for consumers, the planet, and the business’s economics.

Overall, Kimberly‑Clark’s stock has fallen 17% over the past year, reflecting investor concerns about the near‑term earnings dip despite the longer‑term growth narrative.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT